References
1. Powell FC, Collins S. Pyoderma gangrenosum. Clinics in dermatology. 2000;18(3):283-93.
2. Ye MJ, Ye JM. Pyoderma gangrenosum: a review of clinical features and outcomes of 23 cases requiring inpatient management. Dermatology research and practice. 2014;2014:461467.
3. Skopis M, Bag-Ozbek A. Pyoderma gangrenosum: a review of updates in diagnosis, pathophysiology and management. J. 2021;4(3):367-75.
4. Callen JP. Pyoderma gangrenosum and related disorders. Medical Clinics of North America. 1989;73(5):1247-61.
5. Bhat RM. Pyoderma gangrenosum: An update. Indian dermatology online journal. 2012;3(1):7.
6. Braswell SF, Kostopoulos TC, Ortega-Loayza AG. Pathophysiology of pyoderma gangrenosum (PG): an updated review. Journal of the American Academy of Dermatology. 2015;73(4):691-8.
7. Brooklyn T, Dunnill G, Probert C. Diagnosis and treatment of pyoderma gangrenosum. Bmj. 2006;333(7560):181-4.
8. Kozono K, Nakahara T, Kikuchi S, Itoh E, Kido‐Nakahara M, Furue M. Pyoderma gangrenosum with increased levels of serum cytokines. The Journal of Dermatology. 2015;42(12):1186-8.
9. Kwon HI, Paek JO, Kim JE, Ro YS, Ko JY. Pyoderma gangrenosum in a patient with hereditary spherocytosis. The International Journal of Lower Extremity Wounds. 2016;15(1):92-5.
10. Jena A, Sachan A, Singh AK, Sharma V. Multifocal pyoderma Gangrenosum at presentation in a patient with acute severe ulcerative colitis. Inflammatory Bowel Diseases. 2022;28(6):e84-e5.